0455.HK - Tianda Pharmaceuticals Limited

HKSE - HKSE Delayed Price. Currency in HKD
Currency in HKD

Valuation Measures

Market Cap (intraday) 5
346.16M
Enterprise Value 3
60.56M
Trailing P/E
134.17
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.66
Price/Book (mrq)
0.47
Enterprise Value/Revenue 3
0.12
Enterprise Value/EBITDA 6
2.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.01
52-Week Change 3-32.80%
S&P500 52-Week Change 318.53%
52 Week High 30.255
52 Week Low 30.161
50-Day Moving Average 30.182
200-Day Moving Average 30.199

Share Statistics

Avg Vol (3 month) 366.4k
Avg Vol (10 day) 323k
Shares Outstanding 52.15B
Float 466.95M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 40.65%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.60%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4291.67%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 2, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.53%
Operating Margin (ttm)1.62%

Management Effectiveness

Return on Assets (ttm)0.55%
Return on Equity (ttm)1.72%

Income Statement

Revenue (ttm)523.33M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)-1.40%
Gross Profit (ttm)424.08M
EBITDA 21.11M
Net Income Avi to Common (ttm)2.76M
Diluted EPS (ttm)0.001
Quarterly Earnings Growth (yoy)4.20%

Balance Sheet

Total Cash (mrq)343.48M
Total Cash Per Share (mrq)0.16
Total Debt (mrq)6.47M
Total Debt/Equity (mrq)0.84
Current Ratio (mrq)4.06
Book Value Per Share (mrq)0.34

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A